DHELIVER: Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF)

HepaStem (heterologous human adult liver-derived mesenchymal stem cells) - Promethera Biosci

http://clinicaltrials.gov/ct2/show/NCT04229901

Jan 4, 2022